ECSS
RMD icon

Eurizon Capital SGR SpA’s ResMed RMD Stock Holding History

Eurizon Capital SGR SpA’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Sell
30,561
-178,971
-85% -$37.1M 0.02% 403
2026
Q1 		$47M Sell
209,532
-6,661
-3% -$1.66M 0.15% 139
2025
Q4 		$52.1M Buy
+216,193
New +$55.3M 0.16% 111

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Eurizon Capital SGR SpA's RMD Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its ResMed (RMD) stake by 85% in Q2 2026, selling an estimated $37.1M and leaving 30,561 shares worth $5.96M. The position accounts for 0.02% of the portfolio, ranked #403.

Eurizon Capital SGR SpA first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $52.1M in Q4 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Eurizon Capital SGR SpA held 30,561 shares of ResMed worth $5.96M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 178,971 ResMed shares in Q2 2026, an estimated $37.1M.
  • ResMed made up 0.02% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #403 holding.
  • Eurizon Capital SGR SpA first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's ResMed position peaked at $52.1M in Q4 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.